Can Vancevi Medical Insurance be reimbursed?

The generic name of Valcyte is Valganciclovir (Valganciclovir). It is an antiviral drug mainly used to treat cytomegalovirus (CMV) infection, especially for patients with organ transplantation or compromised immune function. The drug is already on the market in China, but it has not yet been included in the national medical insurance list, so patients need to bear the full cost of the drug.

As of now, Vancevi has not been included in the national medical insurance directory, and patients who purchase the drug domestically need to pay for it at their own expense. Because it is an original drug, it is relatively expensive. One box (450mg*60tablets) costs about more than 10,000 yuan. Although some places may provide local medical insurance reimbursement policies for specific groups or special diseases, in general, Vancevi is still not a universally covered medical insurance reimbursement drug. Patients can consult local medical insurance agencies or hospitals to find out whether there are local reimbursement policies.

In some countries, Vancevir may be included in their medical insurance or insurance coverage, especially for high-risk groups such as organ transplant patients or people with HIV-related cytomegalovirus infection. These patients have clear treatment needs and high long-term medication costs. Therefore, some countries include them in medical insurance coverage in order to reduce the financial burden on patients. However, specific policies vary from country to country, and you need to refer to each country’s medical insurance rules.

For domestic patients, if the financial pressure is high, some drug charities may provide free or discounted drug support. Choose legal overseas versions: such as the Indian or Turkish version of the original drug, which costs about three to four thousand yuan, and the drug ingredients and efficacy are consistent with those in China. The National Medical Insurance Directory is updated every year, and patients can pay attention to whether Vancevi will be included in medical insurance.

Regardless of whether they choose the domestic or foreign version, patients must strictly follow the doctor's instructions and monitor blood indicators regularly during treatment to prevent adverse reactions. For eligible patients, you can try to negotiate with your doctor to adjust the treatment plan and find more cost-effective drug alternatives.

xa0

Reference materials

"National Medical Insurance Drug Catalog (2023 Edition)" http://www.nhsa.gov.cn/